113 related articles for article (PubMed ID: 7840317)
1. Hemodynamic response to vasopressin during V1-receptor antagonism in baroreflex-deficient subjects.
Huch KM; Runyan KR; Wall BM; Gavras H; Cooke CR
Am J Physiol; 1995 Jan; 268(1 Pt 2):R156-63. PubMed ID: 7840317
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of vasopressin following V(1) receptor blockade compared to effects of nitroglycerin.
Cooke CR; Wall BM; Huch KM; Mangold T
Am J Physiol Regul Integr Comp Physiol; 2001 Sep; 281(3):R887-93. PubMed ID: 11507005
[TBL] [Abstract][Full Text] [Related]
3. Role of V1 receptors in the action of vasopressin on the baroreflex control of heart rate.
Luk J; Ajaelo I; Wong V; Wong J; Chang D; Chou L; Reid IA
Am J Physiol; 1993 Sep; 265(3 Pt 2):R524-9. PubMed ID: 8214142
[TBL] [Abstract][Full Text] [Related]
4. Arginine vasopressin modulation of arterial baroreflex responses in fetal and newborn sheep.
Nuyt AM; Segar JL; Holley AT; O'Mara MS; Chapleau MW; Robillard JE
Am J Physiol; 1996 Dec; 271(6 Pt 2):R1643-53. PubMed ID: 8997365
[TBL] [Abstract][Full Text] [Related]
5. Pressor dose responses and baroreflex sensitivity in quadriplegic spinal cord injury patients.
Krum H; Louis WJ; Brown DJ; Howes LG
J Hypertens; 1992 Mar; 10(3):245-50. PubMed ID: 1315821
[TBL] [Abstract][Full Text] [Related]
6. Exogenous arginine vasopressin does not enhance carotid baroreflex control in the conscious dog.
Wolfer RS; Lovell NH; Brunner MJ
Am J Physiol; 1994 May; 266(5 Pt 2):R1510-6. PubMed ID: 8203628
[TBL] [Abstract][Full Text] [Related]
7. Effects of vasopressin V1-receptor blockade during acute and sustained hypovolemic hypotension.
Wall BM; Huch KM; Runyan KR; Williams HH; Gavras H; Cooke CR
Am J Physiol; 1996 Feb; 270(2 Pt 2):R356-64. PubMed ID: 8779866
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of vasopressin release during controlled reduction in arterial pressure.
Wall BM; Runyan KR; Williams HH; Bobal MA; Crofton JT; Share L; Cooke CR
J Lab Clin Med; 1994 Oct; 124(4):554-63. PubMed ID: 7930879
[TBL] [Abstract][Full Text] [Related]
9. Effect of AVP.V1-receptor antagonist on urinary albumin excretion and renal hemodynamics in NIDDM nephropathy: role of AVP.V1-receptor.
Yamada K; Nakano H; Nishimura M; Yoshida S
J Diabetes Complications; 1995; 9(4):326-9. PubMed ID: 8573758
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin and renin-angiotensin maintain arterial pressure during PEEP in nonexpanded, conscious dogs.
Kaczmarczyk G; Vogel S; Krebs M; Bünger H; Scholz A
Am J Physiol; 1996 Nov; 271(5 Pt 2):R1396-402. PubMed ID: 8945979
[TBL] [Abstract][Full Text] [Related]
11. During acute hypercapnia vasopressin inhibits an angiotensin drive to ventilation in conscious dogs.
Walker JK; Jennings DB
J Appl Physiol (1985); 1995 Sep; 79(3):786-94. PubMed ID: 8567518
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man.
Ebert TJ; Cowley AW; Skelton M
J Clin Invest; 1986 Apr; 77(4):1136-42. PubMed ID: 3514673
[TBL] [Abstract][Full Text] [Related]
13. Role of vasopressin in acutely altered baroreflex sensitivity during hemorrhage in rats.
Brizzee BL; Russ RD; Walker BR
Am J Physiol; 1991 Sep; 261(3 Pt 2):R677-85. PubMed ID: 1887955
[TBL] [Abstract][Full Text] [Related]
14. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin.
Ervin MG; Ross MG; Leake RD; Fisher DA
Am J Physiol; 1992 Apr; 262(4 Pt 2):R636-43. PubMed ID: 1566929
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular actions of vasopressin: baroreflex modulation in the conscious rat.
Webb RL; Osborn JW; Cowley AW
Am J Physiol; 1986 Dec; 251(6 Pt 2):H1244-51. PubMed ID: 3789178
[TBL] [Abstract][Full Text] [Related]
16. Reflex effect of vasopressin after blockade of V1 receptors in the area postrema.
Hasser EM; Bishop VS
Circ Res; 1990 Aug; 67(2):265-71. PubMed ID: 2376071
[TBL] [Abstract][Full Text] [Related]
17. Physiological arginine vasopressin levels do not enhance baroreflex function in normal humans.
Goldsmith SR
Am J Physiol; 1994 Jun; 266(6 Pt 2):H2374-9. PubMed ID: 8023998
[TBL] [Abstract][Full Text] [Related]
18. Effect of baroreceptor denervation on the inhibition of renin release by vasopressin.
Gregory LC; Quillen EW; Keil LC; Reid IA
Endocrinology; 1988 Jul; 123(1):319-27. PubMed ID: 3289894
[TBL] [Abstract][Full Text] [Related]
19. Baroreflex buffering of pressor response to vasopressin is mediated by V1, not V2, receptors in conscious rats.
Shimizu K; Schwartz J; McGrath BP
Am J Physiol; 1993 Feb; 264(2 Pt 2):R345-9. PubMed ID: 8447490
[TBL] [Abstract][Full Text] [Related]
20. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
